#ScholarRock has won its first product #approval, 14 years after it was founded, as the #FDA gives a green light to its #spinalmuscularatrophy (SMA) therapy Isembyld.
@pharmaphorum.bsky.socialExplore
@pharmaphorum.bsky.social
@pharmaphorum.bsky.social#ScholarRock has won its first product #approval, 14 years after it was founded, as the #FDA gives a green light to its #spinalmuscularatrophy (SMA) therapy Isembyld.